Concepedia

David A. Cameron

DA

Statistics

Publications

3

Citations

36

H-Index

3

Active since

2020

Affiliations

University of British Columbia(Current)

Simon Fraser University

David A. Cameron is an author at University of British Columbia specializing in cost-effectiveness analysis, oncology, and pharmacoeconomics.

ORCID

Publications per year

2020–2022

3

Publications

3

Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada

Graeme Ball, Christopher Lemieux, David A. Cameron et al. · Current Oncology · 2022 · 13 citations · Full text

, , +15

Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care

Adam Raymakers, David A. Cameron, Scott Tyldesley et al. · Current Oncology · 2021 · 12 citations · Full text

, , +16

Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis

Adam Raymakers, Sarah Costa, David A. Cameron et al. · BMC Cancer · 2020 · 11 citations · Full text

, , +14

1–3 of 3